SPY337.44+4.64 1.39%
DIA280.04+2.85 1.03%
IXIC11,012.24+229.42 2.13%

Aurinia Pharmaceuticals Q3 EPS $(0.21) Misses $(0.15) Estimate, Sales $230K Beat $50K Estimate

Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.15) by 40 percent. This is unchanged from the same period last year. The company

Benzinga · -

Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.15) by 40 percent. This is unchanged from the same period last year. The company reported quarterly sales of $230 thousand which beat the analyst consensus estimate of $50 thousand by 360.00 percent. This is a 38.67 percent decrease over sales of $375 thousand the same period last year.